Myriad Genetics MYGN shares rallied 8.3% in the last trading session to close at $5.88. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over ...

Myriad Genetics Inc. (NASDAQ:MYGN) shares rallied 35.7%, to $5.25 in after-hours trading on Tuesday following second-quarter results that exceeded analyst expectations and raised full-year revenue ...

$MYGN insiders have traded $MYGN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Here’s a ...

We just covered 10 Stocks That Tanked: Why Larry Robbins’ Top Picks Are Struggling in 2026 and Myriad Genetics, Inc. (NASDAQ:MYGN) ranks 8th on this list. Myriad Genetics, Inc. (NASDAQ:MYGN) has been ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Piper Sandler upgraded MYGN to "overweight" from "neutral" Medical equipment stock Myriad Genetics Inc (NASDAQ:MYGN) was last seen up 9.8% at $11.25, after an upgrade from Piper Sandler to "overweight ...

Detailed price information for Halozyme Therapeutic (HALO-Q) from The Globe and Mail including charting and trades.